Ambrx Biopharma Inc ADR (AMAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AMAM | AZN | AMGN | GILD | BMY |
| Company | Ambrx Biopharma Inc ADR | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 27.99 | 168.15 | 373.97 | 137.61 | 60.87 |
| High | 28.00 | 170.31 | 378.54 | 140.61 | 62.29 |
| Low | 27.98 | 167.15 | 361.72 | 134.09 | 60.47 |
| Latest | 28.00 | 168.90 | 366.29 | 134.28 | 60.74 |
| Change | +0.02 | -0.39 | -5.29 | -2.02 | +0.23 |
| % Change | +0.07% | -0.23% | -1.42% | -1.48% | +0.38% |
| Volume | 1,439,600 | 1,981,300 | 2,861,300 | 6,903,200 | 12,261,400 |
| 20-Day Average Volume | 1,545,680 | 2,663,130 | 2,584,295 | 8,218,880 | 13,569,005 |
| Previous Close | 27.98 | 169.29 | 371.58 | 136.30 | 60.51 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 27.86 | 180.61 | 359.57 | 129.53 | 57.34 |
| 20-Day Raw Stochastic | 94.23% | 13.92% | 72.47% | 65.18% | 82.49% |
| 20-Day Relative Strength | 80.97 | 40.75 | 57.04 | 54.74 | 58.32 |
| Weighted Alpha | +89.90 | +9.45 | +24.00 | +19.54 | +29.06 |
| Today's Opinion | 100% Buy | 88% Sell | 72% Buy | 8% Sell | 56% Buy |
| Previous Opinion | 100% Buy | 88% Sell | 72% Buy | 8% Buy | 56% Buy |
| Last Month's Opinion | 100% Buy | 56% Sell | 40% Buy | 56% Sell | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.21% since 02/28/24 | -1.58% since 07/10/26 | +0.80% since 07/10/26 | +3.43% since 07/10/26 | +5.49% since 07/10/26 |
| Low | 27.93 on 03/01/24 | 164.45 on 07/14/26 | 353.95 on 07/15/26 | 127.93 on 07/13/26 | 56.78 on 07/14/26 |
| High | 28.00 on 03/06/24 | 170.47 on 07/13/26 | 378.54 on 07/17/26 | 140.61 on 07/17/26 | 62.29 on 07/17/26 |
| 1-Month | |||||
| %Chg | +0.79% since 02/06/24 | -5.05% since 06/17/26 | +7.21% since 06/17/26 | +7.04% since 06/17/26 | +9.88% since 06/17/26 |
| Low | 27.51 on 02/20/24 | 164.45 on 07/14/26 | 334.05 on 06/18/26 | 122.43 on 06/18/26 | 53.44 on 06/18/26 |
| High | 28.03 on 02/26/24 | 196.41 on 07/02/26 | 378.54 on 07/17/26 | 140.61 on 07/17/26 | 62.29 on 07/17/26 |
| 3-Month | |||||
| %Chg | +132.75% since 12/06/23 | -17.53% since 04/17/26 | +3.09% since 04/17/26 | -2.44% since 04/17/26 | +0.95% since 04/17/26 |
| Low | 11.74 on 12/12/23 | 164.45 on 07/14/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 28.15 on 01/10/24 | 203.37 on 04/20/26 | 378.54 on 07/17/26 | 140.61 on 07/17/26 | 62.29 on 07/17/26 |
| 6-Month | |||||
| %Chg | +111.32% since 09/06/23 | -10.53% since 01/16/26 | +10.86% since 01/16/26 | +7.50% since 01/16/26 | +9.92% since 01/16/26 |
| Low | 6.55 on 10/23/23 | 164.45 on 07/14/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 28.15 on 01/10/24 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,768,200 | 261,948,336 | 197,689,664 | 166,718,016 | 124,035,400 |
| Shares Outstanding, K | 63,150 | 1,550,908 | 539,708 | 1,241,570 | 2,042,071 |
| Annual Sales | 7,400,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -78,000,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 1,120,000 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -17,830,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | -1.92 | 0.24 | 0.41 | 0.32 | 0.23 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.05 on 08/09/23 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 04/04/24 | 07/27/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | 0.630 on 07/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 07/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.28 | 16.81 | 16.28 | 10.20 |